
    
      Open-Label, Balanced, Randomized,Two-Treatment, Two-Sequence, Two-Period, Single-Dose,
      Crossover Oral Bioequivalence Study Of Ibandronate Sodium 150 mg Tablets Of Dr. Reddy's
      Laboratories Limited, India And 'BONIVAÂ®' 150 mg (Ibandronate Sodium)Tablets Of Roche
      Laboratories Inc., USA In Healthy, Adult, Human Subjects Under Fasting Conditions (With As
      Many Postmenopausal Women As Possible).
    
  